All Articles

The deal with Sample Healthcare signals a major shift from managing data to using AI to execute revenue cycle tasks, tackling costs and staffing shortages.

A global pioneer and a top US expert join forces to bring a minimally invasive pain therapy to millions of Americans through a revolutionary outpatient model.

A new AI parenting app, Kung Fu Family, promises personalized advice. But as it learns your child, it raises big questions about privacy and tech's role in family life.

A new AI model is beating human traders at their own game. But as EchoZ-1.0's predictions prove startlingly accurate, it raises a critical question.

As legacy groups evolve, Trail Life USA's growth highlights a parental demand for explicit values, challenging the very idea of a 'neutral' space for kids.

Sellers returned to the Mid-Atlantic housing market in March, but rising rates and global conflict are creating an uneven and unpredictable spring season.

Activist investor Summer Road fires back at Ingles Markets, accusing the grocer of misleading shareholders and using "fearmongering" tactics in a bitter board fight.

Gartner's new Adversarial Exposure Validation category signals a major shift in cybersecurity. Find out how AI-driven platforms like Hadrian are leading the way.

After a massive reverse stock split and a tumultuous offering, Linkers Industries finalizes its capital overhaul. Is this a strategic reset or a crisis averted?

A new state-backed tool lets Nevadans compare hospital costs, but providers warn of unintended consequences. Is this the future of healthcare transparency?

European digital health firm Apomeds launches in the UK, targeting the booming telehealth market with a focus on discreet, high-demand treatments.

NASDAQ-listed financial consultant ATIF is expanding into digital assets, guiding clients through the complex world of RWA tokenization and crypto regulation.

European care leader Clariane's oversubscribed €500M bond offering highlights strong investor trust and a strategic move to fortify its financial future.

Landmark trial shows proton therapy boosts survival and cuts side effects, offering new hope as cancer rates climb in adults under 50.

A new IP firm, led by an industry veteran, acquired 500+ Avaya networking patents. The move signals a new era for tech licensing and innovation.

A group known for challenging pandemic rules will now advise on US vaccine policy. Can it rebuild trust, or will it deepen the medical divide?

Lead Real Estate’s ENT TERRACE hotels secure prestigious Booking.com awards, reflecting a successful strategy in Japan's booming extended-stay market.

Lupin has launched a generic version of the blockbuster diabetes drug Farxiga, signaling lower costs for patients and a major shake-up in the SGLT2 market.

Onix launches Personal Intelligence®, an AI trained on trusted experts, not the internet, promising total privacy with locally stored, encrypted data.

As the tax deadline nears, experts warn of illegal 'ghost preparers' who vanish after filing fraudulent returns, leaving taxpayers to face the IRS alone.